The sale is pre-planned under a 10b5-1 program and is small relative to market cap. Monitor for any acceleration of insider selling or changes in the trading plan. No immediate read-through for the stock.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Oct 28 $37.52entry
- T+1 · 6d ago −1.63%α +0.15% · $36.91
- T+5 · due 9h ago Pending
- T+5 · todayOpen
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Eric Venker, an officer of Roivant Sciences, filed a Form 144 notice of intent to sell 200,000 common shares valued at approximately $7.3 million. The sale is planned under a Rule 10b5-1 trading plan adopted on June 30, 2026, and the shares were acquired through option exercises and RSU vesting. The proposed sale represents a small fraction of the company's $26.0B market cap and appears to be a routine diversification move by an insider.
Key Facts
- Eric Venker (officer) filed Form 144 to sell 200,000 common shares.
- Estimated aggregate value of the proposed sale is $7,317,764.00.
- Sale is pursuant to a Rule 10b5-1 trading plan adopted on June 30, 2026.
- Shares were acquired via option exercises (grant date April 2022) and RSU grants (grant dates May 2020, May 2021).
- Company market cap is $26.0B; the sale value is ~0.03% of market cap.
- Recent insider activity (30 days prior) shows 2 sells totaling $7.0M.
Financial Impact
Proposed sale of 200,000 shares valued at ~$7.3M, representing ~0.03% of market cap.
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur.
- Insider selling could increase if additional shares are registered under the plan.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001965301-26-000167 |
| Document: 0001965301-26-000167-index.html | 0001965301-26-000167 |
| Document: 0001965301-26-000167.txt | 0001965301-26-000167 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 3, 2026 today | 144 | $35.56 | awaiting T+60 | awaiting T+60 | $38.23 (+7.51%) |
Oct 30, 2026 5d ago | Institutional Cluster | $36.91 | awaiting T+60 | awaiting T+60 | $38.23 (+3.58%) |
Oct 28, 2026 6d ago | 144 | $37.52 | awaiting T+60 | awaiting T+60 | $38.23 (+1.89%) |
Oct 27, 2026 7d ago | SC 13G/A | $37.11 | awaiting T+60 | awaiting T+60 | $38.23 (+3.02%) |
Oct 21, 2026 14d ago | 8-K | $36.80 | awaiting T+60 | awaiting T+60 | $38.23 (+3.89%) |
Oct 5, 2026 29d ago | Insider Cluster | $35.53 | awaiting T+60 | awaiting T+60 | $38.23 (−7.60%) |
Sep 17, 2026 6w ago | Insider Cluster | $39.77 | awaiting T+60 | awaiting T+60 | $38.23 (−3.87%) |
Sep 17, 2026 6w ago | Insider Cluster | $39.77 | awaiting T+60 | awaiting T+60 | $38.23 (−3.87%) |
Sep 17, 2026 6w ago | Insider Cluster | $39.77 | awaiting T+60 | awaiting T+60 | $38.23 (−3.87%) |
Sep 1, 2026 9w ago | Insider Cluster | $34.18 | awaiting T+60 | awaiting T+60 | $38.23 (+11.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers